← Leaderboards
Bernard A Fox
Providence Portland Medical Center
$5,302,432
Attributed
$5,302,432
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $513.8K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$5,302,432 · 3
By mechanism
R01$5,302,432 · 3
Top collaborators
No co-investigators on record.
Most similar at Providence Portland Medical Center
Same institution · by research overlap
- Hong-Ming Hu$1,630,963
- Walter J Urba$2,009,864
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaT LymphocyteLaboratory MouseNeoplasm /Cancer ImmunologyNeoplasm /Cancer VaccineNeoplasm /Cancer ImmunotherapyAntineoplasticsImmunotherapyResearch PersonnelCd8b1 GeneTumorT-LymphocyteVaccinationResponseFailure (Biologic Function)Adoptive TransferReconstitutionImmune ResponseCancer VaccinesVaccinesBaseBackPeripheral Blood Mononuclear CellClinical Trials
Grant awards (21)
Mechanisms That Regulate Tumor-Specific Immune Responses$248,940
R01 · FY2014 · CA · contact PI
Mechanisms That Regulate Tumor-Specific Immune Responses$241,241
R01 · FY2013 · CA · contact PI
Mechanisms That Regulate Tumor-Specific Immune Responses$256,639
R01 · FY2012 · CA · contact PI
Mechanisms That Regulate Tumor-Specific Immune Responses$256,639
R01 · FY2011 · CA · contact PI
Mechanisms That Regulate Tumor-Specific Immune Responses$264,576
R01 · FY2010 · CA · contact PI
Exploiting Lymphopenia to Augment the Adoptive Immunotherapy of Melanoma Patients$245,258
R01 · FY2009 · CA · contact PI
Exploiting Lymphopenia to Augment the Adoptive Immunotherapy of Melanoma Patients$245,258
R01 · FY2008 · CA · contact PI
Mechanisms That Regulate Tumor-Specific Immune Responses$253,661
R01 · FY2007 · CA · contact PI
Exploiting Lymphopenia to Augment the Adoptive Immunotherapy of Melanoma Patients$245,258
R01 · FY2007 · CA · contact PI
Mechanisms That Regulate Tumor-Specific Immune Responses$261,237
R01 · FY2006 · CA · contact PI
Exploiting Lymphopenia to Augment the Adoptive Immunotherapy of Melanoma Patients$252,583
R01 · FY2006 · CA · contact PI
Mechanisms That Regulate Tumor-Specific Immune Responses$267,524
R01 · FY2005 · CA
Mechanisms That Regulate Tumor-Specific Immune Responses$267,524
R01 · FY2004 · CA
Identify and amplify T cell effector mechanisms$265,745
R01 · FY2004 · CA
Mechanisms That Regulate Tumor-Specific Immune Responses$267,524
R01 · FY2003 · CA
Identify and amplify T cell effector mechanisms$265,745
R01 · FY2003 · CA
Identify and amplify T cell effector mechanisms$265,745
R01 · FY2002 · CA
MECHANISMS THAT REGULATE TUMOR SPECIFIC IMMUNE RESPONSES$228,451
R01 · FY2002 · CA
Identify and amplify T cell effector mechanisms$265,745
R01 · FY2001 · CA
MECHANISMS THAT REGULATE TUMOR SPECIFIC IMMUNE RESPONSES$221,799
R01 · FY2001 · CA
MECHANISMS THAT REGULATE TUMOR SPECIFIC IMMUNE RESPONSES$215,340
R01 · FY2000 · CA